City
Companies in Singapore, Singapore (city)
VCMC tracks 11,335 companies based in Singapore, Singapore (city). 502 of them have raised a venture or growth round, $27.66B in total, with a median round of $7.0M; 161 raised since 2024. 492 of the 502 have a VCMC valuation; the median is $27.7M.
11,335
companies tracked
502
venture-backed
4% of those tracked
$27.66B
raised in total
by 456 companies
$7.0M
median round
of 647 rounds with an amount
$27.7M
median valuation
of 492 companies valued
Values cover private companies only; public companies are not included.
By their latest round, most are at Seed (184 of 502).
- Pre-seed 52
- Seed 184
- Series A 129
- Series B 62
- Series C and later 73
- Stage not stated 2
The companies
Companies in Singapore, Singapore (city)
The 50 venture-backed companies below are this page's list; OYO has raised the most ($2.91B).
| # | Last round | History | Range | Trend | Grade | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | OYO Hotels | Series G Aug 2024 $174M | $2.9B | $1.0B – $3.5B | $2.4B (-17%) | $392M | 12% | 15,451 | flat | C | |
| 2 | Binance Cryptocurrency | Growth Equity Jun 2025 $2.00B | $22.3B | $11.9B – $34.0B | $22.3B (0%) | $2.3B | 0% | 14,720 | up | B | |
| 3 | Digital Edge Data Solutions | Growth Equity Jan 2025 $1.60B | $21.8B | $12.1B – $33.2B | $21.8B (0%) | $2.3B | 0% | – | growing | B | |
| 4 | Airwallex Payment Processing & Point of Sale | Series H Jun 2026 $320M | $12.0B | $9.6B – $16.7B | $14.5B (+20%) | $1.8B | 0% | 2,937 | growing | A | |
| 5 | Ant International Payment Processing & Point of Sale | Series A Jul 2026 $1.20B | $6.8B | $3.8B – $15.9B | $10.4B (+54%) | $1.7B | 0% | 2,565 | growing | C | |
| 6 | Supabase Tech Companies | Series F Jun 2026 $500M | $11.9B | $9.1B – $16.6B | $14.4B (+21%) | $1.8B | 0% | 455 | growing | A | |
| 7 | Trax Tech Companies | Series E Apr 2021 $640M | $730M | $348M – $2.6B | $646M (-12%) | $812M | 97% | 575 | shrinking | D | |
| 8 | Aspire Payment Processing & Point of Sale | Growth Equity Jan 2024 $79M | $930M | $196M – $1.4B | $878M (-6%) | $96.2M | 0% | 1,112 | flat | C | |
| 9 | Funding Societies Loans & Financing | Growth Equity Dec 2024 $25M | $237M | $95.3M – $391M | $215M (-10%) | $26.9M | 24% | 481 | flat | C | |
| 10 | Amber Group Investment Consultants & Financial Advisors | Series C Dec 2022 $300M | $3.1B | $395M – $4.3B | $2.9B (-7%) | $500M | 0% | 614 | flat | D | |
| 11 | Tyme Group Banks & ATMs | Series D Dec 2024 $250M | $2.3B | $1.4B – $2.7B | $2.3B (0%) | $297M | 0% | 485 | up | B | |
| 12 | Carro Automobile Dealers & Manufacturers | Growth Equity Sep 2025 $60M | $664M | $384M – $1.0B | $664M (0%) | $68.8M | 0% | 1,383 | up | B | |
| 13 | Electronical Components Manufacturing | Series B Jun 2026 $150M | $1.1B | $612M – $2.1B | $1.4B (+29%) | $177M | 0% | 237 | up | C | |
| 14 | Medical Supply Manufacturers | Growth Equity Oct 2010 $219M | $1.5B | $96.8M – $3.2B | $1.5B (0%) | $241M | 0% | 503 | flat | D | |
| 15 | Biotechnology | Series A Jan 2018 $76M | $220M | $24.1M – $530M | $219M (-1%) | $106M | 30% | 44 | flat | D | |
| 16 | Biotechnology | Series B May 2025 $45M | $338M | $140M – $557M | $299M (-12%) | $52.3M | 39% | 29 | flat | C | |
| 17 | Debt Collection Agencies | Growth Equity Sep 2020 $60M | $488M | $37.6M – $882M | $488M (0%) | $66.0M | 0% | 432 | up | D | |
| 18 | Biotechnology | Growth Equity Mar 2025 $49M | $578M | $281M – $879M | $578M (0%) | $59.8M | 0% | 72 | up | B | |
| 19 | Biotechnology | Series A May 2021 $43M | $168M | $11.0M – $508M | $157M (-6%) | $64.3M | 23% | 35 | flat | D | |
| 20 | Loans & Financing | Growth Equity Apr 2025 $27M | $179M | $85.0M – $255M | $179M (0%) | $18.6M | 0% | 26 | unknown | B | |
| 21 | Electronical Components Manufacturing | Series C Sep 2014 $38M | $166M | $14.4M – $438M | $166M (0%) | $49.4M | 16% | 249 | flat | D | |
| 22 | Electrical & Wiring Contractors | Acquisition Apr 2026 | $293M acquired 2026 | $21.3M – $447M | – | – | 0% | 188 | up | D | |
| 23 | Electronical Components Manufacturing | Acquisition Apr 2016 $11M | $319M acquired 2016 | $19.0M – $485M | – | – | 0% | – | unknown | D | |
| 24 | Biotechnology | Series A May 2024 $26M | $270M | $102M – $411M | $199M (-26%) | $43.5M | 0% | 36 | growing | C | |
| 25 | Renewable energy companies | Growth Equity Jan 2021 $25M | $136M | $16.1M – $392M | $126M (-7%) | $30.0M | 36% | 109 | flat | D | |
| 26 | Electronical Components Manufacturing | Other Nov 2025 $9.7M | $57.6M | $12.5M – $96.0M | $57.6M (0%) | $11.5M | 7% | 57 | growing | D | |
| 27 | Pharmaceutical Products | Other Jun 2026 $17M | $60.0M | $1.11M – $303M | $59.7M (0%) | $4.12M | 33% | 139 | up | D | |
| 28 | Chemicals | Series A Feb 2023 $12M | $50.8M | $7.77M – $147M | $41.3M (-19%) | $18.8M | 41% | 33 | flat | D | |
| 29 | Tech Companies | Seed Aug 2026 $13M | $86.1M | $49.5M – $229M | $151M (+75%) | $31.2M | 0% | 27 | flat | C | |
| 30 | Loans & Financing | Series B May 2023 $6.6M | $22.5M | $7.50M – $96.4M | $17.3M (-23%) | $8.75M | 89% | 32 | flat | D | |
| 31 | Tech Companies | Series B Apr 2023 $8.5M | $76.1M | $11.7M – $129M | $73.3M (-4%) | $10.9M | 0% | 372 | up | D | |
| 32 | Tech Companies | Series A Nov 2019 $12M | $36.8M | $3.81M – $96.4M | $35.6M (-3%) | $16.8M | 35% | 72 | flat | D | |
| 33 | Electronical Components Manufacturing | Series A Mar 2026 $8.3M | $57.5M | $27.1M – $113M | $74.2M (+29%) | $11.9M | 0% | 34 | up | C | |
| 34 | Loans & Financing | Series A May 2025 $8.5M | $54.5M | $20.6M – $91.5M | $45.9M (-16%) | $11.8M | 44% | 34 | flat | C | |
| 35 | Loans & Financing | Seed Mar 2026 $8.0M | $71.2M | $30.5M – $141M | $92.8M (+30%) | $19.2M | 0% | 4 | unknown | C | |
| 36 | Recruitment & Job Listing Services | Series A Nov 2022 $7.5M | $12.8M | $3.84M – $69.8M | $9.49M (-26%) | $10.5M | 87% | 34 | down | D | |
| 37 | Pharmaceutical Products | Grant Jun 2024 $3.3M | $35.8M | $4.53M – $54.4M | $31.8M (-11%) | $7.40M | 0% | 9 | unknown | D | |
| 38 | Bicycle Rental Services | Series A Jul 2023 $6.0M | $36.7M | $3.71M – $90.4M | $33.0M (-10%) | $10.0M | 5% | 29 | flat | D | |
| 39 | Medical Supply Manufacturers | Series A Sep 2020 $4.7M | $30.8M | $1.12M – $62.2M | $30.8M (0%) | $6.58M | 0% | 2 | unknown | D | |
| 40 | Medical Supply Manufacturers | Series A Aug 2026 $3.0M | $16.6M | $10.3M – $37.3M | $26.3M (+58%) | $4.24M | 0% | 5 | unknown | C | |
| 41 | Pharmaceutical Products | Seed Jun 2026 $4.0M | $29.3M | $15.2M – $70.6M | $46.4M (+58%) | $9.60M | 0% | 10 | unknown | C | |
| 42 | Fish Farms | Seed Oct 2021 $3.5M | $9.96M | $1.40M – $54.6M | $10.3M (+4%) | $8.84M | 72% | 26 | flat | D | |
| 43 | Medical Supply Manufacturers | Series A Dec 2023 $3.5M | $16.2M | $4.62M – $45.7M | $11.9M (-27%) | $5.05M | 54% | 16 | up | D | |
| 44 | Loans & Financing | Seed May 2025 $3.2M | $40.2M | $14.5M – $57.0M | $40.2M (0%) | $8.32M | 0% | 35 | growing | C | |
| 45 | Ice Cream | Other May 2025 $1.1M | $9.45M | $0.33M – $20.0M | $9.31M (-2%) | $2.06M | 18% | 33 | flat | D | |
| 46 | Business Associations | Seed May 2022 $1.5M | $2.03M | $0.66M – $13.4M | $1.71M (-16%) | $3.07M | 93% | – | down | D | |
| 47 | Neurology Clinics | Seed Aug 2023 $2.1M | $6.70M | $2.01M – $23.0M | $5.72M (-15%) | $4.66M | 81% | 21 | down | D | |
| 48 | Translation Services | Seed Aug 2025 $1.5M | $8.44M | $5.20M – $14.2M | $5.53M (-35%) | $3.60M | 97% | 10 | down | B | |
| 49 | Loans & Financing | Seed May 2022 $1.5M | $12.9M | $0.54M – $22.1M | $12.9M (0%) | $3.00M | 0% | 4 | unknown | D | |
| 50 | Loans & Financing | Seed Dec 2019 | $20.0M | $0.50M – $47.8M | $20.0M (0%) | $4.97M | 0% | 4 | unknown | D |
Showing 50 of 11,335. Load more lists every other company here, 50 at a time.
Valuations
How these companies are valued
492 of the 502 venture-backed companies here have a VCMC valuation; the median is $27.7M. A company acquired after its last round keeps its last value as a private company and is left out of the median. 53 companies have disclosed a valuation; for the rest VCMC's valuation is the only number. Each valuation comes with a range, from a low to a high scenario, and a prediction for a year from now. Values cover private companies only; public companies are not included. How VCMC values companies.
Investors
Who backs them
Firms that backed two or more of these companies. SEEDS Capital backed 29, Wavemaker Partners 23.
- 29 companies, led 1
- 23 companies, led 10
- 500 Global 19 companies, led 3
- 15 companies, led 3
- 15 companies, led 1
- EDBI 13 companies, led 1
- Y Combinator 12 companies, led 3
- HSG 11 companies, led 4
- Sequoia Capital India 11 companies, led 4
- Temasek 11 companies, led 4
- SGInnovate 11 companies, led 2
- 11 companies, led 1
Recent rounds
Latest funding
44 rounds from Oct 2025 to Sep 2026, $3.39B with a disclosed amount.
- Series A, with Cocoon Capital and ContInvest $3.0M 26 Aug 2026
- Seed, led by Jump Crypto $13M 15 Aug 2026
- Ant International Series A, with Ant Group and Alibaba Group $1.20B 21 Jul 2026
- Seed, with SGInnovate and Lotus Singapore $3.9M 17 Jul 2026
- Airwallex Series H+, led by Addition $320M 25 Jun 2026
- Seed, led by Wavemaker Ventures $4.0M 22 Jun 2026
- Series B, with Trip.com Group Ltd. and SenseTime Group Inc. $296M 19 Jun 2026
- Seed, led by Fuel Ventures Asia $1.0M 18 Jun 2026
- Seed, led by Singapore-based family office $1.0M 18 Jun 2026
- Series B, with Hillhouse and Maverick Capital $150M 8 Jun 2026
- Supabase Series F, led by GIC $500M 4 Jun 2026
- Series A, with Cathay Venture and MLC Ventures $4.0M 1 Jun 2026
Browse
Related groups
Industries in Singapore, Singapore (city)
Other cities in Singapore
Questions
Frequently asked
How many companies in Singapore, Singapore (city) does VCMC track?
11,335. 502 of them have raised a venture or growth round.
How much have companies in Singapore, Singapore (city) raised?
$27.66B in total across the 456 with a known amount; the median round is $7.0M. 161 raised a round since 2024.
Which companies in Singapore, Singapore (city) have raised the most?
OYO ($2.91B), Binance ($2.00B), Digital Edge ($1.60B).
Which investors back companies in Singapore, Singapore (city) most often?
SEEDS Capital (29 companies), Wavemaker Partners (23 companies), 500 Global (19 companies).
What are companies in Singapore, Singapore (city) worth?
The median VCMC valuation is $27.7M across 492 companies; companies acquired after their last round are left out. Values cover private companies only; public companies are not included.
What was the latest funding round?
Bioactivx raised a Series A round of $3.0M (Aug 2026), with Cocoon Capital and ContInvest.